{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:38:24Z","timestamp":1794134304350,"version":"4.8.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular circulating hormonal system, it is now accepted as a local tissue system that works synergistically or independently with the circulating one. Evidence states that tissue RAAS locally generates mediators with regulatory homeostatic functions, thus contributing, at some extent, to organ dysfunction or disease. Specifically, RAAS can be divided into the traditional RAAS pathway (or classic RAAS) mediated by angiotensin II (AII), and the non-classic RAAS pathway mediated by angiotensin 1\u20137. Both pathways operate in the heart and lung. In the heart, the classic RAAS plays a role in both hemodynamics and tissue remodeling associated with cardiomyocyte and endothelial dysfunction, leading to progressive functional impairment. Moreover, the local classic RAAS may predispose the onset of atrial fibrillation through different biological mechanisms involving inflammation, accumulation of epicardial adipose tissue, and electrical cardiac remodeling. In the lung, the classic RAAS regulates cell proliferation, immune-inflammatory response, hypoxia, and angiogenesis, contributing to lung injury and different pulmonary diseases (including COVID-19). Instead, the local non-classic RAAS counteracts the classic RAAS effects exerting a protective action on both heart and lung. Moreover, the non-classic RAAS, through the angiotensin-converting enzyme 2 (ACE2), mediates the entry of the etiological agent of COVID-19 (SARS-CoV-2) into cells. This may cause a reduction in ACE2 and an imbalance between angiotensins in favor of AII that may be responsible for the lung and heart damage. Drugs blocking the classic RAAS (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers) are well known to exert a cardiovascular benefit. They are recently under evaluation for COVID-19 for their ability to block AII-induced lung injury altogether with drugs stimulating the non-classic RAAS. Herein, we discuss the available evidence on the role of RAAS in the heart and lung, summarizing all clinical data related to the use of drugs acting either by blocking the classic RAAS or stimulating the non-classic RAAS.<\/jats:p>","DOI":"10.3389\/fphar.2021.667254","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T06:26:09Z","timestamp":1618899969000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19"],"prefix":"10.3389","volume":"12","author":[{"given":"Annamaria","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Scavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Rafaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Cappetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberato","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1096\/fj.08-114611","article-title":"JunD and HIF\u20101\u03b1 Mediate Transcriptional Activation of Angiotensinogen by TGF\u2010\u03b21 in Human Lung Fibroblasts","volume":"23","author":"Abdul-Hafez","year":"2009","journal-title":"FASEB j."},{"key":"B2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11906-014-0429-9","article-title":"Angiotensin-(1-12): A Chymase-Mediated Cellular Angiotensin II Substrate","volume":"16","author":"Ahmad","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"B3","unstructured":"HFSA\/ACC\/AHA statement addresses concerns re: using RAAS antagonists in COVID-192020"},{"key":"B4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.peptides.2013.11.006","article-title":"An Orally Active Angiotensin-(1-7) Inclusion Compound and Exercise Training Produce Similar Cardiovascular Effects in Spontaneously Hypertensive Rats","volume":"51","author":"Bertagnolli","year":"2014","journal-title":"Peptides"},{"key":"B5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0735-1097(03)00578-3","article-title":"Fibrosis of the Left Atria during Progression of Heart Failure Is Associated with Increased Matrix Metalloproteinases in the Rat","volume":"42","author":"Boixel","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2003.07.014","article-title":"Expression of Angiotensin II Receptors in Human Left and Right Atrial Tissue in Atrial Fibrillation with and without Underlying Mitral Valve Disease","volume":"42","author":"Boldt","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s004180000235","article-title":"Distribution of Type-1 and Type-2 Angiotensin Receptors in the Normal Human Lung and in Lungs from Patients with Chronic Obstructive Pulmonary Disease","volume":"115","author":"Bullock","year":"2001","journal-title":"Histochem. Cel Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/cancers12061457","article-title":"Renin-angiotensin System in Lung Tumor and Microenvironment Interactions","volume":"12","author":"Catarata","year":"2020","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical Evaluation of the Renin-Angiotensin System: The Good, Bad, and Absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/SHK.0b013e3182a6953e","article-title":"Dysregulated Renin-AngioteNsin System Contributes to Acute Lung Injury Caused by Hind-Limb Ischemia-Reperfusion in Mice","volume":"40","author":"Chen","year":"2013","journal-title":"Shock"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1046\/j.1523-1755.1998.06719.x","article-title":"Physiological and Pharmacological Implications of AT1 versus AT2 Receptors","volume":"67","author":"Chung","year":"1998","journal-title":"Kidney Int. Suppl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ahj.2004.01.026","article-title":"Prognostic Significance of Raised Plasma Levels of Interleukin-6 and C-Reactive Protein in Atrial Fibrillation","volume":"148","author":"Conway","year":"2004","journal-title":"Am. Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2017.01.027","article-title":"Carcinogenic Risk and Bisphenol A Exposure: A Focus on Molecular Aspects in Endoderm Derived Glands","volume":"457","author":"Cuomo","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, MAS, in Experimental Models of Arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J.I."},{"key":"B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and Inflammation: The Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2589-7500(20)30294-6","article-title":"Renin\u2013angiotensin System Inhibitors and COVID-19: Overwhelming Evidence against an Association","volume":"3","author":"de Abajo","year":"2020","journal-title":"Lancet Digit. Heal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19 Requiring Admission to Hospital: a Case-Population Study","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.108.114280","article-title":"Molecular Mechanisms Involved in the angiotensin-(1-7)\/Mas Signaling Pathway in Cardiomyocytes","volume":"52","author":"Dias-Peixoto","year":"2008","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.envpol.2018.09.058","article-title":"A Systematic Risk Characterization Related to the Dietary Exposure of the Population to Potentially Toxic Elements through the Ingestion of Fruit and Vegetables from a Potentially Contaminated Area. A Case Study: The Issue of the \u201cLand of Fires\u201d Area in Campania Region, Italy","volume":"243","author":"Esposito","year":"2018","journal-title":"Environ. Pollut."},{"key":"B21","unstructured":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers2020"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0735-1097(01)01170-6","article-title":"Activation of the Cardiac Renin-Angiotensin System and Increased Myocardial Collagen Expression in Human Aortic Valve Disease","volume":"37","author":"Fielitz","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of Hypertension and Antihypertensive Treatment with COVID-19 Mortality: a Retrospective Observational Study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/cid\/ciaa634","article-title":"Therapy with Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"71","author":"Gnavi","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting Enzyme 2 Inhibits Lung Injury Induced by Respiratory Syncytial Virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","article-title":"The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak - an Update on the Status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/cvr\/cvu045","article-title":"Epicardial Adipose Tissue and Atrial Fibrillation","volume":"102","author":"Hatem","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","article-title":"Age and Multimorbidity Predict Death Among COVID-19 Patients","volume":"76","author":"Iaccarino","year":"2020","journal-title":"Hypertension"},{"key":"B34","unstructured":"GUIDA CLINICA COVID-19 PER CARDIOLOGI2020"},{"key":"B35","unstructured":"Il comunicato della SIIA | SIIA2020"},{"key":"B36","unstructured":"2020"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1093\/cid\/ciaa624","article-title":"Association of Renin-Angiotensin-Aldosterone System Inhibitors with Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-Based Cohort Study","volume":"71","author":"Jung","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease","volume":"15","author":"Jung","year":"2014","journal-title":"Ijms"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.2174\/092986711796642562","article-title":"Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome","volume":"18","author":"Kaparianos","year":"2011","journal-title":"Curr Med Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12020-010-9328-2","article-title":"Preliminary Biochemical Characterization of the Novel, Non-AT1, Non-AT2 Angiotensin Binding Site from the Rat Brain","volume":"37","author":"Karamyan","year":"2010","journal-title":"Endocr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","article-title":"Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction","volume":"2","author":"Kassiri","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"B42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A Pilot Clinical Trial of Recombinant Human Angiotensin-Converting Enzyme 2 in Acute Respiratory Distress Syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejcts.2010.05.006","article-title":"Protective Effect of Epicardial Adiponectin on Atrial Fibrillation Following Cardiac Surgery","volume":"39","author":"Kourliouros","year":"2011","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.chest.2019.04.015","article-title":"Association of Angiotensin Modulators with the Course of Idiopathic Pulmonary Fibrosis","volume":"156","author":"Kreuter","year":"2019","journal-title":"Chest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: Should Inhibitors of the Renin-Angiotensin System Be Withdrawn in Patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur. Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fnana.2014.00067","article-title":"Brain Renin-Angiotensin System and Dopaminergic Cell Vulnerability","volume":"8","author":"Labandeira-Garc\u00eda","year":"2014","journal-title":"Front. Neuroanat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs with Ventricular Tachypacing-Induced Congestive Heart Failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijcard.2009.07.015","article-title":"Enalapril, Irbesartan, and Angiotensin-(1-7) Prevent Atrial Tachycardia-Induced Ionic Remodeling","volume":"146","author":"Liu","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.regpep.2009.12.020","article-title":"Angiotensin-(1-7) Prevents Atrial Fibrosis and Atrial Fibrillation in Long-Term Atrial Tachycardia Dogs","volume":"162","author":"Liu","year":"2010","journal-title":"Regul. Peptides"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial Fibrillation in Heart Failure: Epidemiology, Pathophysiology, and Rationale for Therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijcard.2006.08.061","article-title":"Influence of Epicardial Adipose Tissue and Adipocytokine Levels on Cardiac Abnormalities in Visceral Obesity","volume":"121","author":"Malavazos","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/nejmoa2006923","article-title":"Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the Renin-Angiotensin System in Vascular Inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/1381612033455431","article-title":"The Pulmonary Renin-Angiotensin System","volume":"9","author":"Marshall","year":"2003","journal-title":"Curr Pharm Des."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00143","article-title":"Renin-angiotensin System and Coronavirus Disease 2019: A Narrative Review","volume":"7","author":"Mascolo","year":"","journal-title":"Front. Cardiovasc. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ijcard.2016.10.069","article-title":"New and Old Roles of the Peripheral and Brain Renin-Angiotensin-Aldosterone System (RAAS): Focus on Cardiovascular and Neurological Diseases","volume":"227","author":"Mascolo","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10741-019-09837-7","article-title":"Angiotensin II and Angiotensin 1-7: Which Is Their Role in Atrial Fibrillation?","volume":"25","author":"Mascolo","year":"","journal-title":"Heart Fail. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2013.5818","article-title":"The Angiotensin-Converting Enzyme 2\/angiotensin (1-7)\/mas axis Protects against Lung Fibroblast Migration and Lung Fibrosis by Inhibiting the NOX4-Derived ROS-Mediated RhoA\/Rho Kinase Pathway","volume":"22","author":"Meng","year":"2015","journal-title":"Antioxid. Redox Signaling"},{"key":"B60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.parkreldis.2014.12.008","article-title":"Quitting Smoking: An Early Non-motor Feature of Parkinson's Disease?","volume":"21","author":"Moccia","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cca.2005.12.012","article-title":"Lisinopril Ameliorates Paraquat-Induced Lung Fibrosis","volume":"367","author":"Mohammadi-Karakani","year":"2006","journal-title":"Clinica Chim. Acta"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2174\/138161207780618777","article-title":"Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-\u03b2 (TGF-\u03b2) and \u03b1-Actomyosin (\u03b1 SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis","volume":"13","author":"Molteni","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.amjhyper.2006.09.016","article-title":"Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats with Visceral Fat Obesity","volume":"20","author":"Mori","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"B64","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCEP.112.971200","article-title":"Does Location of Epicardial Adipose Tissue Correspond to Endocardial High Dominant Frequency or Complex Fractionated Atrial Electrogram Sites during Atrial Fibrillation?","volume":"5","author":"Nagashima","year":"2012","journal-title":"Circ. Arrhythm Electrophysiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.hrthm.2014.04.040","article-title":"Epicardial Adipose Tissue-Based Defragmentation Approach to Persistent Atrial Fibrillation: Its Impact on Complex Fractionated Electrograms and Ablation Outcome","volume":"11","author":"Nakahara","year":"2014","journal-title":"Heart Rhythm"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation","volume":"101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2125.2008.03234.x","article-title":"The Role of the Renin-Angiotensin System in Atrial Fibrillation and the Therapeutic Effects of ACE-Is and ARBS","volume":"66","author":"Novo","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"B69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","article-title":"ACE2\/Ang 1-7 axis: A Critical Regulator of Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Obesity","volume":"5","author":"Patel","year":"","journal-title":"Adipocyte"},{"key":"B70","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cjca.2016.12.012","article-title":"Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure","volume":"33","author":"Patel","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"db150399","DOI":"10.2337\/db15-0399","article-title":"ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity","volume":"65","author":"Patel","year":"","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/obr.12471","article-title":"Molecular Targets of Developmental Exposure to Bisphenol A in Diabesity: a Focus on Endoderm-Derived Organs","volume":"18","author":"Porreca","year":"2017","journal-title":"Obes. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1465-9921-5-24","article-title":"Gene Expression Profiling Reveals Novel TGF\u03b2 Targets in Adult Lung Fibroblasts","volume":"5","author":"Renzoni","year":"2004","journal-title":"Respir. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/nejmoa2008975","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijcard.2016.03.080","article-title":"The Pathophysiological Role of Natriuretic Peptide-RAAS Cross Talk in Heart Failure","volume":"226","author":"Rossi","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/cei.12612","article-title":"Human Monocyte Subsets Exhibit Divergent Angiotensin I-Converting Activity","volume":"181","author":"Rutkowska-Zapa\u0142a","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT1 Receptor Blockers as Treatments for Inflammatory Brain Disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting Enzyme 2, Angiotensin-(1-7) and Mas: New Players of the Renin-Angiotensin System","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The Renin-Angiotensin System: Going beyond the Classical Paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-012-1489-2","article-title":"Effect of Combination of Renin Inhibitor and Mas-Receptor Agonist in DOCA-Salt-Induced Hypertension in Rats","volume":"373","author":"Singh","year":"2013","journal-title":"Mol. Cel. Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/europace\/eur402","article-title":"Role of Inflammation in Early Atrial Fibrillation Recurrence","volume":"14","author":"Smit","year":"2012","journal-title":"Europace"},{"key":"B82","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/AJPHEART.00217.2020","article-title":"COVID-19, ACE2, and the Cardiovascular Consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1-7) Decreases LPS-Induced Inflammatory Response in Macrophages","volume":"227","author":"Souza","year":"2012","journal-title":"J. Cel. Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A Population-Based Study of the Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-Up of the Renfrew\/Paisley Study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am. J. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.scitotenv.2019.04.202","article-title":"Ecological Risk and Estimates of Organophosphate Pesticides Loads into the Central Mediterranean Sea from Volturno River, the River of the \u201cLand of Fires\u201d Area, Southern Italy","volume":"678","author":"Triassi","year":"2019","journal-title":"Sci. Total Environ."},{"key":"B86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: From Vasopeptidase to SARS Virus Receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2174\/138161207780618885","article-title":"Angiotensin-TGF-\u03b21 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages","volume":"13","author":"Uhal","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0002-9149(01)02321-9","article-title":"The Role of the Renin-Angiotensin System in the Development of Cardiovascular Disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/nejmsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human Epicardial Adipose Tissue Induces Fibrosis of the Atrial Myocardium through the Secretion of Adipo-Fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur. Heart J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"L143","DOI":"10.1152\/ajplung.2000.279.1.l143","article-title":"Abrogation of Bleomycin-Induced Epithelial Apoptosis and Lung Fibrosis by Captopril or by a Caspase Inhibitor","volume":"279","author":"Wang","year":"2000","journal-title":"Am. J. Physiology-Lung Cell Mol. Physiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"147032031875526","DOI":"10.1177\/1470320318755269","article-title":"Irbesartan Prevents Sodium Channel Remodeling in a Canine Model of Atrial Fibrillation","volume":"19","author":"Wang","year":"2018","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"B93","doi-asserted-by":"publisher","first-page":"ehw045","DOI":"10.1093\/eurheartj\/ehw045","article-title":"Epicardial Fat and Atrial Fibrillation: Current Evidence, Potential Mechanisms, Clinical Implications, and Future Directions","volume":"38","author":"Wong","year":"2017","journal-title":"Eur. Heart J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute Respiratory Distress Syndrome Leads to Reduced Ratio of ACE\/ACE2 Activities and Is Prevented by Angiotensin-(1-7) or an Angiotensin II Receptor Antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/ATVBAHA.111.237198","article-title":"Macrophage Polarization by Angiotensin II-type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis","volume":"31","author":"Yamamoto","year":"2011","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.phrs.2012.05.001","article-title":"Characterization of Angiotensin-(1-7) Effects on the Cardiovascular System in an Experimental Model of Type-1 Diabetes","volume":"66","author":"Yousif","year":"2012","journal-title":"Pharmacol. Res."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-015-0044-3","article-title":"Angiotensin-(1-7) Improves Oxygenation, while Reducing Cellular Infiltrate and Fibrosis in Experimental Acute Respiratory Distress Syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"ICMx"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/CIRCULATIONAHA.104.530592","article-title":"Angiotensin II Potentiates the Slow Component of Delayed Rectifier K + Current via the at 1 Receptor in Guinea Pig Atrial Myocytes","volume":"113","author":"Zankov","year":"2006","journal-title":"Circulation"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.31713410.1161\/circresaha.120.317242","article-title":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the Cardiovascular System","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"78726","DOI":"10.18632\/oncotarget.20221","article-title":"Angiotensin-converting Enzyme-2 Overexpression Improves Atrial Electrical Remodeling through TRPM7 Signaling Pathway","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting Enzyme 2 Protects from Lethal Avian Influenza A H5N1 Infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.667254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T16:20:16Z","timestamp":1619540416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.667254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":103,"alternative-id":["10.3389\/fphar.2021.667254"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.667254","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"article-number":"667254"}}